Evidence map›Paper›PMID 36928234›Full record

ArticleJMIR formative research2023

Correction: Effectiveness of Secondary Risk-Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study.

Jelena Maksimenko, Pedro Pereira Rodrigues, Miki Nakazawa-Miklaševiča, David Pinto, Edvins Miklaševičs, Genadijs Trofimovičs, Jānis Gardovskis, Fatima Cardoso, Maria João Cardoso

Full text readPublished Erratum
In one paragraph

Article in JMIR formative research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Jelena MaksimenkoInstitute of Oncology, Department of Surgery, Breast Unit, Pauls Stradiņš Clinical University Hospital, Riga Stradiņš University, Riga, Latvia.ORCID 0000-0003-2462-3125
Pedro Pereira RodriguesInformation and Health Decision Sciences of the Faculty of Medicine, University of Porto, Porto, Portugal.ORCID 0000-0001-7867-6682
Miki Nakazawa-MiklaševičaInstitute of Oncology, Riga Stradiņš University, Riga, Latvia.ORCID 0000-0001-8198-0060
David PintoBreast Cancer Unit, Champalimaud Cancer Center, Lisbon, Portugal.ORCID 0000-0002-7998-3366
Edvins MiklaševičsInstitute of Oncology, Riga Stradiņš University, Riga, Latvia.ORCID 0000-0002-7817-4268
Genadijs TrofimovičsFaculty of Medicine, Rīga Stradiņš University, Riga, Latvia.ORCID 0000-0001-6433-1499
Jānis GardovskisDepartment of Surgery, Faculty of Medicine, Pauls Stradins Clinical University Hospital, Rīga Stradiņš University, Riga, Latvia.ORCID 0000-0001-9656-6209
Fatima CardosoBreast Cancer Unit, Champalimaud Cancer Center, Lisbon, Portugal.ORCID 0000-0002-6692-2249
Maria João CardosoBreast Cancer Unit, Champalimaud Cancer Center, Lisbon, Portugal.ORCID 0000-0002-8137-3700

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: .].

Identifiers

PMID36928234
PMCPMC10019764

What OpenQuestion holds

Textfull text, public
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.